CytomX Therapeutics
New generation of fully recombinant, protease-activated monoclonal antibodies that can achieve unprecedented levels of tissue-specific targeting.
Get a Demo and See the Full Profile
Get a demo today to see profiles of CytomX Therapeutics plus 5908 other startups.
